Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients

Inclusion Criteria: * Subjects or their legal representatives, who have read, understood and signed a written informed consent. * Subjects of either sex. * Female subjects of childbearing potential with a negative urine or serum pregnancy test on admission. * Subjects who are \<= 65 years of age including pediatric subjects of all ages. * Subjects with total burn wounds measuring \<= 40% TBSA. * Subjects with a contiguous deep partial thickness/full thickness wound, between 2% and 8% TBSA or two comparable, bilateral wounds each measuring between 1% and 4% TBSA. * Wounds designated as test sites require autologous sheet skin grafts with a thickness of 8/1000" - 16/1000" * Subjects who are able, and willing to comply with the procedures required by the protocol. Exclusion Criteria: * Subjects with electrical burns. * Subjects with chemical burns * Digits and genitalia are excluded as test sites. * Subjects with infection at test area/test sites. * Subjects with test sites previously randomized and treated in this study. * Subjects with venous or arterial vascular disorder that directly affects a designated test area/test site. * Subjects with pre-existing hemolytic anemia * Subjects with diabetes mellitus. * Subjects with documented history of pathologically or pharmacologically induced immune deficiency. * Subjects judged to be chronically malnourished. * Subjects that are judged to have significant pulmonary compromise. * Subjects receiving systemic corticosteroids within 30 days prior to skin grafting (not including inhaled steroids). * Subjects with known or suspected hypersensitivity to bovine proteins. * Subjects participating in another clinical trial that is evaluating an unapproved drug or device.